Of the 50 dogs enrolled, 48 completed the whole study. Dogs were orally treated with afoxolaner three times at monthly intervals. multi-centre field trial was conducted to evaluate the efficacy of afoxolaner based chewables (NexGard® or NexGard Spectra®) for the treatment of generalised demodicosis caused by Demodex canis in dogs under field conditions in France, Italy and Poland.Ĭlient-owned dogs, diagnosed positive for Demodex mites by pre-treatment skin scrapings and presenting clinical signs of generalised demodicosis were included. 10 Boehringer Ingelheim Animal Health, 29 avenue Tony Garnier, 69007, Lyon, France. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |